Loss of Neupogen sales to U.S. biosimilars 2015-2017

Published by
Matej Mikulic
,
Jul 22, 2019
This statistic depicts the value of filgrastim sales from Neupogen compared to its U.S. biosimilar competitors from 2015 to 2017. In 2015, Neupogen generated 810.05 million dollars in sales in the United States. As of November 2017, Neupogen sales decreased to 400.2 million U.S. dollars.

Sales of Neupogen compared to its U.S. biosimilars from 2015 to 2017 (in million U.S. dollars)

CharacteristicNeupogen (originator)Zarxio (biosimilar)Granix (biosimilar)
- - - -
- - - -
- - - -
Showing entries 1 to 3 (3 entries in total)
Statistic: Sales of Neupogen compared to its U.S. biosimilars from 2015 to 2017 (in million U.S. dollars)

© Statista 2025
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

February 2018

Region

United States

Survey time period

2015 to 2017

Supplementary notes

* Year to date November 2017.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Spain "

Other statistics that may interest you Pharmaceutical industry in Spain

Overview

6

Pharmaceutical sales

6

Pharmaceutical expenditure of the National Health System

6

Leading companies

6

International trade

6

Research and development

6

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceuticals in IndiaGlobal pharmaceutical industryPharmaceutical industry in JapanPharmaceutical industry in ChinaPharmaceutical industry in South Korea
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$1,299 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.